1
Clinical Trials associated with MIBI-Tc99m/Iodine-123 / Active, not recruitingPhase 2/3IIT Value of the Combination Ultrasonography With Ti-RADS Score / Dual Tracer Scintigraphy MIBI-Tc99m/Iodine-123 in the Detection of Malignancy of Thyroid Nodules (Sup or Egal to 15 mm) Classified Bethesda III or IV on Cytology
The main objective of the study is to show that the addition of ultrasonography to the dual tracer scintigraphy MIBI-Tc99m/Iodine-123 will increase (at least +5%) the negative predictive value compared to the dual tracer scintigraphy alone in detection of malignancy in thyroid nodules ≥15 mm classified as Bethesda III-IV on cytology.
100 Clinical Results associated with MIBI-Tc99m/Iodine-123
100 Translational Medicine associated with MIBI-Tc99m/Iodine-123
100 Patents (Medical) associated with MIBI-Tc99m/Iodine-123
100 Deals associated with MIBI-Tc99m/Iodine-123